CD4 ϩ and CD8 ϩ T cells exhibit important differences in their major effector functions. CD8 ϩ T cells provide protection against pathogens through cytolytic activity, whereas CD4 ϩ T cells exert important regulatory activity through production of cytokines. However, both lineages can produce interferon (IFN)-␥ , which can contribute to protective immunity. Here we show that CD4 ϩ and CD8 ϩ T cells differ in their regulation of IFN-␥ production. Both lineages require signal transducer and activator of transcription (Stat)4 activation for IFN-␥ induced by interleukin (IL)-12/IL-18 signaling, but only CD4 ϩ T cells require Stat4 for IFN-␥ induction via the TCR pathway. In response to antigen, CD8 ϩ T cells can produce IFN-␥ independently of IL-12, whereas CD4 ϩ T cells require IL-12 and Stat4 activation. Thus, there is a lineage-specific requirement for Stat4 activation in antigen-induced IFN-␥ production based on differences in TCR signaling between CD4 ϩ and CD8 ϩ T cells.
I nterferon (IFN)-␥ enhances defense against bacterial and viral pathogens (1) and is produced by both innate and adaptive immune cells, including NK cells, CD8 ϩ T cells, and CD4 ϩ T cells. NK cells are an important source of IFN-␥ in early infection, and can secrete IFN-␥ upon initial activation (2) . In contrast, CD4 ϩ cells produce little IFN-␥ on primary activation and require cytokine-dependent differentiation to acquire this capacity (3, 4) . Further, CD4 ϩ T cells exhibit a developmental dichotomy diverging to either an IFN-␥ -producing (Th1) or IL-4-producing (Th2) phenotype (5, 6) . A similar paradigm was recently extended to CD8 ϩ T cells, where Tc1 and Tc2 subsets develop in response to conditions that induce Th1 and Th2 subsets (7) (8) (9) (10) . However, unlike Th2 cells, Tc2 cells retain the capacity for IFN-␥ production, although reduced compared with Tc1 cells, and produce quantitatively less IL-4 relative to their CD4 counterpart (7) .
For CD4 ϩ T cells, Th1/Th2 polarization involves IL-12 and IL-4 signaling via the JAK-STAT Janus kinases/signal transducer and activator of transcription) pathway (11) (12) (13) (14) (15) . The role of IL-12 in Th1 development was established using both IL-12-and Stat4-deficient mice (12, 13, 16) . IL-12 p40-deficient mice had impaired NK responses and lower IFN-␥ production from CD4 ϩ T cells (16) , but IFN-␥ secretion by LAK cells and generation of allo-specific CTL were unimpeded. These studies suggested IL-12-independent pathways in NK cells and CTLs. Stat4-deficient mice exhibit reduced but not absent IFN-␥ production (12, 13) , but the source was not apparent, since these studies used unseparated splenocytes and polyclonal activation. In sum, these studies suggest not all cell types are entirely IL-12 and Stat4 dependent for IFN-␥ production.
The TCR pathway has been considered the only physiologic stimuli for IFN-␥ induction in CD4 ϩ T cells. However, IL-12 and IL-18 were shown to induce IFN-␥ production in Th1 cells by a TCR-independent mechanism (17). The pathways activated by TCR and IL-12/IL-18 treatment are differentially sensitive to Cyclosporin A inhibition and appear to induce IFN-␥ transcription through activation of distinct sets of factors (18) . Thus the requirements for Stat4 and IL-12 in IFN-␥ production may depend on the activating stimulus as well as the cell type.
In this study, we directly compared the CD4 ϩ and CD8 ϩ T cells for IL-12 and Stat4 requirements in IFN-␥ induction through the TCR or IL-12/IL-18 pathways. We find that CD4 ϩ and CD8 ϩ T cells exhibit lineage-specific differences in requiring Stat4-activation for IFN-␥ production. Specifically, both CD4 ϩ and CD8 ϩ T cells require Stat4 in IL-12/IL-18 induction of IFN-␥ , but only CD4 ϩ T cells require Stat4 for TCR induced IFN-␥ production.
Materials and Methods
Animals. Stat4-deficient DO11.10 TCR-transgenic mice have been described previously (12, 19) . 2C TCR transgenic mice (20) were obtained from Dr. T. Hansen (Washington University, St. Louis, MO).
Cytokines, Antibodies, and Other Reagents. Recombinant human IL-2, IL-4, IL-12, and KJ1-26 (21) were used as previously described (19) . Recombinant murine IL-18 (Research Diagnostics Inc.) was used at 50 ng/ml. Anti-IL-12 (TOSH) (22) and anti-IFN-␥ (H22) (from Dr. R.D. Schreiber, Washington University, St. Louis, MO) were used at 10 g/ml. Anti-CD3 (2C11) (from Dr. A. Shaw, Washington University, St. Louis, MO) was coated at 10 g/ml for primary stimulations and 1 g/ml for secondary stimulation, and anti-CD28 (PV1) (from Dr. Carl June, Naval Medical Research Institute, Bethesda, MD) was used at 1 g/ml. All other staining reagents were purchased from PharMingen.
T Cell Purification and Cultures. Sorted CD4 ϩ DO11.10 T cells (2 ϫ 10 5 /ml) were activated with 0.3 M OVA peptide (OVA), IL-2, IL-12, and irradiated BALB/c splenocytes as previously described (3). In other experiments, DO11.10 splenocytes (3 ϫ 10 6 /ml) were activated with OVA, IL-2, IL-12 (Th1), or IL-4 (Th2) as indicated in the figure legends. CD8 ϩ T cells were sorted from spleen and lymph node cells of 2C mice and activated (2 ϫ 10 5 /ml) using irradiated BALB/c splenocytes (1.5 ϫ 10 6 /ml). CD4 ϩ and CD8 ϩ T cells were sorted from spleen and lymph node cells of Stat4-deficient or wild-type mice, and stimulated (4 ϫ 10 5 /ml) with irradiated C57BL/6 splenocytes (4 ϫ 10 6 /ml), IL-2, and the indicated cytokines and antibodies.
ELISA and Intracellular Cytokine Staining. IFN-␥ was measured by ELISA as previously described (3). Intracellular cytokine staining was performed as described elsewhere (18, 23) . T cells were stimulated overnight with OVA and either irradiated APCs or plate-bound anti-CD3, and Brefeldin A (10 g/ml; Epicenter Technologies) was added for the final 4 h. Cells were harvested, washed, and stained for CD4, CD8, and KJ1-26 as indicated in the figure legends. After washing, cells were fixed, washed, permeabilized, and stained for IFN-␥ .
Results

CD4 ϩ and CD8 ϩ T Cells Have Distinct Requirements for IL-12 and Stat4 in the Production of IFN-␥ .
Previous analyses of Stat4-deficient mice reported five-to sixfold reduced IFN-␥ production based in part on polyclonal cellular activation of unseparated splenocytes (12, 13) . To examine the requirement for Stat4 in antigen-specific CD4 ϩ T cells, we used DO11.10 TCR-transgenic mice crossed to either wildtype or Stat4-deficient backgrounds. Splenocytes from unimmunized mice were primed in vitro and induced toward Th1 and Th2 phenotypes (4) (Fig. 1 A) . As expected, wildtype DO11.10 T cells primed in the presence of IL-12 generated high levels of IFN-␥ upon secondary stimulation. In contrast, Stat4-deficient DO11.10 T cells primed with IL-12 generated nearly 100-fold less IFN-␥ , confirming that Stat4 has a significant role in CD4 ϩ T cells for IFN-␥ production.
After in vitro priming, clonotype-positive (KJ1-26 ϩ ) T cells from wild type DO11.10 transgenic mice are predominantly CD4 ϩ . However, in Stat4-deficient mice, as much as 25% of the KJ1-26 ϩ T cells are CD4 Ϫ (Fig. 1 B) and CD8 Ϫ (not shown) after in vitro priming. Double-negative T cells have been reported to exhibit differences in Th1/Th2 regulation, with impaired Th2 development (24, 25) . Thus, we wished to assess production of IFN-␥ in CD4 ϩ and CD4 Ϫ T cells using intracellular cytokine staining ( Fig. 1 B) . Wildtype DO11.10 T cells produced abundant intracellular IFN-␥ production, whereas Stat4-deficient DO11.10 T cells showed a significantly lower percentage of IFN-␥ -producing cells with lower mean fluorescence intensities relative to wildtype T cells (Fig. 1 B) . Of the Stat4-deficient DO11.10 T cells, 6% of CD4 ϩ cells produced IFN-␥ , whereas 13% of CD4 Ϫ negative cells produced IFN-␥ , implying that in KJ1-26 ϩ T cells, CD4 ϩ cells are more Stat4 dependent for IFN-␥ production than are CD4 Ϫ cells. These and other results suggest that IFN-␥ production may be regulated differently in various T cell lineages (16, 26 , and Carter, L.L., unpublished observations). Therefore, we wished to compare CD4 ϩ and CD8 ϩ T cells from TCRtransgenic mice for their dependence on IL-12 for driving IFN-␥ production (Fig. 1 C) . CD8 ϩ or CD4 ϩ T cells were sorted from 2C TCR-transgenic mice or DO11.10 mice, respectively, and primed with antigen in the presence of IL-12 or anti-IL-12 antibody for 6 d, restimulated, and assessed for IFN-␥ production. CD4 ϩ DO11.10 T cells produced high IFN-␥ when primed with IL-12, but virtually undetectable IFN-␥ when primed with anti-IL-12 antibody (Fig. 1 C) . In contrast, 2C CD8 ϩ T cells produced high levels of IFN-␥ even when primed in the presence of anti-IL-12 antibody, with IFN-␥ production being reduced only twofold relative to cells primed with IL-12. Thus, CD8 ϩ T cells show significant IL-12-independent IFN-␥ production, whereas CD4 ϩ T cells do not.
In the mouse, Stat4 is uniquely activated by IL-12 (11, 27, 28) . Therefore, IL-12-independent IFN-␥ production by CD8 ϩ T cells suggests either that Stat4 activation is IL-12 independent or that IFN-␥ production is Stat4 independent. To distinguish these possibilities, we analyzed purified CD4 ϩ and CD8 ϩ T cells from Stat4-deficient and wild-type BALB/c mice. T cells were primed in the presence of IL-12 with either allogeneic stimulators or platebound anti-CD3 and anti-CD28 (Fig. 2) . When primed and reactivated with allogeneic stimulators (Fig. 2, left) , Stat4-deficient CD4 ϩ T cells produced very little IFN-␥. In comparison, Stat4-deficient CD8 ϩ T cells produced significantly more IFN-␥, although the level observed was reduced three-to fourfold relative to the wild-type CD8 ϩ control. When T cells were reactivated with anti-CD3 (Fig. 2, middle) , Stat4-deficient CD4 ϩ T cells remained poor IFN-␥ producers, whereas Stat4-deficient CD8 ϩ T cells produced IFN-␥ at levels similar to wild-type CD8 ϩ controls (Fig. 2, middle) . When T cells were primed with anti-CD3/anti-CD28 and IL-12, and reactivated with anti-CD3, Stat4-deficient CD4 ϩ T cells again produced very low levels of IFN-␥, whereas Stat4-deficient CD8 ϩ T cells produced high levels of IFN-␥ (Fig. 2, right) .
We extended these results with intracellular cytokine staining (Fig. 3) . Purified CD4 ϩ and CD8 ϩ T cells from Stat4-deficient and wild-type mice were primed in the presence of IL-12 using either APCs or anti-CD3/anti-CD28, and reactivated with APCs (Fig. 3 A) or anti-CD3 (Fig. 3 B) . CD4 ϩ T cells again showed a strict requirement for Stat4 in IFN-␥ production with both forms of activation. In contrast, Stat4-deficient CD8 ϩ T cells produced abundant IFN-␥ with either form of activation. With anti-CD3 treatment, equivalent percentages of Stat4-deficient and wild-type CD8 ϩ T cells produced IFN-␥, whereas with activation by APCs, IFN-␥ ϩ Stat4-deficient CD8 ϩ T cells were reduced twofold. Thus, in contrast to CD4 ϩ T cells, CD8 ϩ T cells show significant Stat4-independent IFN-␥ production, which is most apparent with direct TCR-mediated cellular activation.
Since APCs can produce IL-12 and IL-18 (4, 29, 30) , T cell activation using APCs could engage both the TCR and the IL-12/IL-18 pathway for IFN-␥ production. Therefore, we asked if these pathways were differentially Stat4 dependent in CD4 ϩ and CD8 ϩ T cells (Fig. 4) . Purified CD4 ϩ and CD8 ϩ T cells from Stat4-deficient and wildtype mice were primed with IL-12 and allogeneic APCs and reactivated on day 6 with either anti-CD3 or IL-12/ IL-18. In response to anti-CD3, wild-type CD4 ϩ , but not Stat4-deficient CD4 ϩ , T cells produced IFN-␥. As above, both wild-type and Stat4-deficient CD8 ϩ T cells produced IFN-␥. However, in response to IL-12/IL-18 treatment, both CD4 ϩ and CD8 ϩ Stat4-deficient T cells failed to produce IFN-␥. Thus, the IL-12/IL-18 pathway for IFN-␥ production is strictly Stat4 dependent in both CD4 ϩ and CD8 ϩ T cells. In contrast, the TCR-induced pathway for IFN-␥ production is Stat4 dependent only in CD4 ϩ , and not CD8 ϩ , T cells.
Discussion
Previous observations have suggested the existence of both IL-12-dependent and -independent pathways for IFN-␥ production (12, 13, 16, (31) (32) (33) . However, since few of these studies analyzed purified cell types, the effects of Stat4 in specific lineages were potentially obscured. Furthermore, recent studies have demonstrated that IFN-␥ gene transcription can be activated by two distinct signaling pathways, one by TCR signaling and other by IL-12 and IL-18 (18) , and these pathways were not individually examined in the previous studies. Therefore, the aim of this study was to analyze differences between CD4 ϩ and CD8 ϩ T cells in their regulation of these two pathways for IFN-␥ production.
In this paper, we make several new observations. First, we show that the IL-12/IL-18 pathway for induction of IFN-␥ operates in CD8 ϩ as well as CD4 ϩ T cells. Second, we formally demonstrate that the IL-12/IL-18 pathway is strictly Stat4 dependent in both CD4 ϩ and CD8 ϩ T cells. Third, we have identified an unexpected difference between CD4 ϩ and CD8 ϩ T cells in TCR signaling. Specifically, CD4 ϩ T cells produce IFN-␥ in a completely Stat4-dependent manner, whereas CD8 ϩ T cells are Stat4 independent for TCR-induced IFN-␥ production.
Common Regulation in CD4 ϩ and CD8 ϩ T Cells for IL-12/ IL-18-induced IFN-␥. Two pathways are now recognized for IFN-␥ induction (17, 18) , one via TCR-signaling and another through IL-12 and IL-18 that acts independently of antigen stimulation (17) . The TCR-and IL-12/IL-18-induced pathways were shown to be pharmacologically distinct and to induce different transcription factors (18) . In this study, we show that IL-12/IL-18 induction of IFN-␥ operates in CD8 ϩ as well as CD4 ϩ T cells (Fig. 4) . The existence of antigen-independent IFN-␥ production by previously activated T cells from both CD4 and CD8 lineage has significant implications for immune regulation. By stimulating production of cytokines in an antigen-independent manner, this pathway allows antigen-specific T cells to operate like innate immune cells. The Stat4-dependence of the IL-12/ IL-18-induced pathway in both CD4 ϩ and CD8 ϩ lineages suggest a common IFN-␥ regulatory mechanism.
Distinct Regulation in CD4 ϩ and CD8 ϩ T Cells for TCR-induced IFN-␥ Production. In contrast to IL-12/IL-18-induced IFN-␥, TCR-induced signaling revealed a striking difference in the requirement for Stat4 between CD4 ϩ and CD8 ϩ T cells. Unseparated Stat4-deficient splenocytes displayed a partial reduction in IFN-␥ production in previous studies (12, 13) , whereas pure populations of CD4 ϩ T cells show a much more stringent requirement for Stat4 (Fig. 1 A) . In contrast, Stat4-deficient CD8 ϩ T cells generated abundant IFN-␥ particularly when activated through the TCR. When CD8 ϩ T cells were activated using APCs, a partial loss of IFN-␥ production was observed in Stat4-deficient CD8 ϩ T cells relative to wild-type controls (Figs. 2, left , and 3 A), suggesting that activation with APCs engages both TCR (Stat4-independent) and IL-12/IL-18 (Stat4-dependent) pathways. Activation of CD8 ϩ T cells using anti-CD3 restricts activation to the TCR (Stat4-independent) pathway, resulting in equivalent levels of IFN-␥ production by Stat4-deficient and wild-type CD8 ϩ T cells. Distinct regulation of IFN-␥ gene activation between CD4 ϩ and CD8 ϩ T cells has previously been suggested (26) . A Stat4-independent mechanism for IFN-␥ production development has recently been described (34) , but as it operated only in the absence of Stat6 and in CD4 ϩ T cells, it is distinct from the pathway described here.
Differences in TCR signaling between CD4 ϩ and CD8 ϩ lineages could reside at several levels. First, CD4 ϩ and CD8 ϩ T cells may differ in expression of signaling components downstream of the TCR. For example, certain mitogen-activated protein (MAP) kinases implicated in IFN-␥ induction (35, 36) could be differentially expressed or activated in CD4 ϩ versus CD8 ϩ T cells, being Stat4 dependent only in CD4 ϩ T cells. Second, chromatin accessibility of the IFN-␥ gene may differ between primary CD4 ϩ and CD8 ϩ lineages. In this model, the IFN-␥ gene would be accessible to TCR-induced factors independently of Stat4 in CD8 ϩ T cells, but not in CD4 ϩ T cells. However, IFN-␥ chromatin structure in CD4 ϩ versus CD8 ϩ T cells has not yet been compared. Finally, coreceptor signaling could account for the present observations. CD8 may provide a signal that bypasses a Stat4 requirement in IFN-␥ production, or conversely CD4 may provide a signal imposing such a requirement. Indeed, differences between coreceptor association with src family kinase Lck have been reported (37) (38) (39) (40) , and lack of CD4 expression impairs Th2 responses (24, 25) .
In summary, the study presented here makes the first distinction between CD4 ϩ and CD8 ϩ T cells for the role of Stat4 in regulation of IFN-␥ expression. Given the importance of IFN-␥ in responses to pathogens and in autoimmune processes, it will be important to determine the basis of these lineage-specific differences in the Stat4-requirement for IFN-␥ gene regulation.
